HIGHLIGHTS
- who: Stine Sofie Frank Lende from the Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, Department of Infectious Diseases, Aarhus have published the paper: CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy, in the Journal: (JOURNAL)
- what: In the recent paper, the authors showed that human STING activation in humanized NOG mice leads to production of human cytokines from human innate immune cells. From the trial , the authors previously reported the plasma levels of IFN-a where the authors observed 12 of 15 trial participants exhibited increases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.